Chickenpox
Summary
Chickenpox (varicella) is a highly contagious primary infection caused by varicella-zoster virus (VZV), a herpesvirus. It is characterised by a generalised vesicular rash (crops of vesicles in different stages) and is typically a mild, self-limiting illness in immunocompetent children. Complications include secondary bacterial skin infection (Group A Streptococcus, Staphylococcus aureus), pneumonitis, encephalitis, and cerebellar ataxia. Chickenpox is more severe in adults, pregnant women, neonates, and immunocompromised individuals. After primary infection, VZV remains latent in dorsal root ganglia and can reactivate later in life as herpes zoster (shingles). Prevention is through vaccination (live attenuated vaccine) and post-exposure prophylaxis with varicella-zoster immunoglobulin (VZIG) in high-risk contacts.
Key Facts
- Causative agent: Varicella-zoster virus (VZV) — Herpesviridae family
- Transmission: Respiratory droplets and direct contact with vesicle fluid; highly contagious
- Incubation period: 10-21 days (typically 14-16 days)
- Infectious period: 2 days before rash until all lesions crusted over (usually 5-7 days)
- Attack rate: >90% in susceptible household contacts
- Classic rash: "Dew drops on a rose petal" — vesicles on erythematous base
- Rash distribution: Centripetal (trunk → spreads to face, limbs); crops at different stages
- Complication rate: 2-5% in children; higher in adults and immunocompromised
- Latency: VZV dormant in dorsal root ganglia; reactivates as shingles
- Vaccine: Live attenuated; part of routine childhood immunisation in many countries
Clinical Pearls
"Starry Sky Rash": The hallmark of chickenpox is crops of vesicles at different stages of development (macules, papules, vesicles, crusts) — the "starry sky" appearance. This distinguishes it from monomorphic rashes.
"No NSAIDs": Avoid NSAIDs (ibuprofen) in chickenpox — associated with increased risk of secondary necrotising fasciitis. Use paracetamol only for fever.
"Adults Get Sicker": Chickenpox is generally mild in children but can be severe in adults, with higher rates of pneumonitis and hospitalisation. Adults should receive aciclovir if presenting within 24 hours.
"Pregnancy Alert": Chickenpox in pregnancy carries risks for mother (varicella pneumonitis) and fetus (congenital varicella syndrome in early pregnancy; severe neonatal varicella if infected around delivery).
"The Prodrome Is Non-Specific": Fever and malaise for 1-2 days before the rash is common. Don't dismiss non-specific symptoms in contacts of known cases.
Why This Matters Clinically
While chickenpox is usually benign in healthy children, it can be life-threatening in high-risk groups (immunocompromised, neonates, pregnant women). Recognising complications early (bacterial superinfection, pneumonitis, encephalitis) and knowing when to use antivirals is essential. Post-exposure prophylaxis with VZIG can prevent or modify disease in high-risk contacts.[1,2]
Incidence & Prevalence
| Parameter | Data |
|---|---|
| Pre-vaccine era incidence | ~90% infected by adolescence in temperate climates |
| UK incidence | ~600,000 cases/year (mostly children) |
| Hospitalisation rate | ~500 per year in UK (children); higher in adults |
| Deaths | ~20 per year in UK (mainly adults, immunocompromised) |
| Peak age | 1-9 years |
| Seasonality | Late winter to early spring peak |
Demographics
| Factor | Details |
|---|---|
| Age distribution | Peak incidence 1-9 years (90% <15 years in unvaccinated populations) |
| Adults without immunity | ~10% of adults susceptible; more severe disease |
| Tropical climates | Higher proportion of adult cases (lower childhood transmission) |
Risk Factors for Severe Disease
| Factor | Risk | Notes |
|---|---|---|
| Age >14 years | 15-25x mortality vs children | Increased pneumonitis risk |
| Pregnancy | 5x increased pneumonitis | Risk of congenital varicella syndrome |
| Neonates | Very high mortality if maternal infection near term | Disseminated disease |
| Immunocompromised | 10-30% mortality without treatment | Leukaemia, HIV, transplant, steroids |
| Chronic skin disease (eczema) | More extensive disease | Eczema herpeticum overlap rare but possible |
Mechanism
Step 1: Primary Infection
- VZV enters via respiratory mucosa (droplet transmission)
- Initial viral replication in nasopharynx and regional lymph nodes
Step 2: Primary Viraemia (~Day 4-6)
- Virus enters bloodstream
- Spreads to reticuloendothelial system (liver, spleen)
- Further amplification
Step 3: Secondary Viraemia (~Day 10-14)
- Massive viral release into bloodstream
- Virus transported to skin and mucous membranes
- Prodrome of fever and malaise begins
Step 4: Skin Manifestations
- VZV infects epidermal cells
- Vesicle formation: Intraepidermal, unilocular vesicles
- "Dew drops on a rose petal" — clear vesicles on erythematous base
- Progressive stages: Macule → papule → vesicle → pustule → crust
- Crops appear over several days (different stages simultaneously)
Step 5: Latency
- VZV travels via sensory nerves to dorsal root ganglia
- Establishes lifelong latent infection
- Reactivation later in life = Herpes Zoster (shingles)
Immune Response
| Component | Role |
|---|---|
| Innate immunity | Initial response; limits early spread |
| Cell-mediated immunity (CMI) | Critical for clearance; deficiency = severe disease |
| Humoral immunity (antibodies) | Prevents reinfection; can be measured (IgG serology) |
| Passive antibody (VZIG) | Provides temporary protection post-exposure |
Prodrome (1-2 Days Before Rash)
| Symptom | Notes |
|---|---|
| Fever | Low-grade (37.5-39°C); higher in adults |
| Malaise | General unwellness |
| Headache | Non-specific |
| Anorexia | Common in children |
Rash Characteristics
| Feature | Description |
|---|---|
| Appearance | "Dew drops on a rose petal" — clear vesicles on erythematous base |
| Evolution | Macule → Papule → Vesicle → Pustule → Crust (24-48 hours per lesion) |
| Distribution | Centripetal: Trunk first → Face → Limbs |
| Crops | New lesions appear in waves over 3-5 days; lesions at different stages simultaneously |
| Mucosal involvement | Oral vesicles/ulcers, genital lesions |
| Number of lesions | Typically 250-500; range 10 to >1000 |
| Pruritus | Intense itching characteristic |
| Crusting | All lesions crust by day 5-7 (marks end of infectious period) |
Red Flags
[!CAUTION] Red Flags — Require Urgent Assessment:
- High persistent fever after day 4 (secondary bacterial infection)
- Rapidly spreading redness/warmth around lesions (cellulitis, necrotising fasciitis)
- Respiratory symptoms (cough, dyspnoea, tachypnoea) — varicella pneumonitis
- Neurological symptoms (ataxia, altered consciousness, seizures)
- Immunocompromised patient with chickenpox
- Pregnant woman with chickenpox (or post-exposure)
- Neonate with chickenpox or exposed <7 days post-delivery
Skin Examination
Key Findings:
- Vesicles on erythematous base ("dew drop on rose petal")
- Lesions at different stages (macules, vesicles, crusts)
- Centripetal distribution (trunk > extremities)
- Mucosal ulcers (oral, conjunctival)
- Check for secondary infection (honey crusting, surrounding erythema)
Documentation:
- Approximate lesion count (mild <50, moderate 50-250, severe >250)
- Signs of bacterial superinfection
- Stage of lesions (all crusted = no longer infectious)
Systemic Examination (If Complications Suspected)
| System | Assessment | Concern |
|---|---|---|
| Respiratory | Cough, tachypnoea, crackles | Varicella pneumonitis |
| Neurological | Ataxia, altered GCS, neck stiffness | Encephalitis, cerebellar ataxia |
| Skin | Spreading erythema, pain, crepitus | Necrotising fasciitis (GAS/S. aureus) |
Routine (Uncomplicated Cases)
No investigations typically required. Diagnosis is clinical.
Investigations If Uncertainty or Severe Disease
| Investigation | Indication | Expected Findings |
|---|---|---|
| VZV PCR (vesicle fluid) | Atypical rash; confirmation needed | Positive |
| Tzanck smear | Rapid bedside test (vesicle scraping) | Multinucleated giant cells (non-specific) |
| VZV IgM/IgG | Confirm immunity; epidemiological | IgM positive = acute; IgG positive = past infection/immunity |
| CXR | Respiratory symptoms | Diffuse nodular infiltrates (pneumonitis) |
| FBC, CRP | Bacterial superinfection suspected | Leukocytosis, raised CRP |
| LFTs | Hepatitis (can occur) | Transaminitis |
| LP | Neurological symptoms | Lymphocytic pleocytosis (encephalitis) |
Management Algorithm
CHICKENPOX MANAGEMENT
↓
┌───────────────────────────────────────────────────────────────┐
│ ASSESS RISK STATUS │
├───────────────────────────────────────────────────────────────┤
│ LOW RISK (Typical): │
│ ➤ Healthy child (age 1-14 years) │
│ ➤ No chronic disease or immunosuppression │
│ ➤ No complications │
├───────────────────────────────────────────────────────────────┤
│ HIGH RISK: │
│ ➤ Adults (>14 years) │
│ ➤ Immunocompromised (steroids, chemo, HIV) │
│ ➤ Pregnant women │
│ ➤ Neonates │
│ ➤ Chronic lung/skin disease │
│ ➤ Smokers │
└───────────────────────────────────────────────────────────────┘
↓
┌───────────────────────────────────────────────────────────────┐
│ MANAGEMENT: LOW-RISK (HEALTHY CHILD) │
├───────────────────────────────────────────────────────────────┤
│ SUPPORTIVE CARE: │
│ ➤ Paracetamol for fever (AVOID NSAIDs) │
│ ➤ Antihistamines (chlorphenamine) for itch │
│ ➤ Calamine lotion │
│ ➤ Keep nails short; consider mittens (prevent scratching) │
│ ➤ Tepid baths │
│ ➤ Adequate fluids │
│ │
│ EXCLUSION: │
│ ➤ Exclude from school until all lesions crusted (~5-7 days) │
│ │
│ NO ANTIVIRALS needed for typical healthy child │
└───────────────────────────────────────────────────────────────┘
↓
┌───────────────────────────────────────────────────────────────┐
│ MANAGEMENT: HIGH-RISK INDIVIDUALS │
├───────────────────────────────────────────────────────────────┤
│ ANTIVIRALS (within 24 hours of rash onset): │
│ ➤ Aciclovir 800 mg 5x daily (adults) for 7 days │
│ ➤ Aciclovir 20 mg/kg QDS (children high-risk) for 5 days │
│ ➤ IV aciclovir for immunocompromised/pneumonitis/enceph │
│ │
│ CONSIDER HOSPITAL ADMISSION: │
│ ➤ Immunocompromised │
│ ➤ Pneumonitis (cough, dyspnoea, hypoxia) │
│ ➤ Encephalitis (ataxia, altered consciousness) │
│ ➤ Secondary bacterial infection (IV antibiotics if severe) │
└───────────────────────────────────────────────────────────────┘
↓
┌───────────────────────────────────────────────────────────────┐
│ SPECIAL SITUATIONS │
├───────────────────────────────────────────────────────────────┤
│ PREGNANCY (Varicella in pregnancy): │
│ ➤ Aciclovir if ≥20 weeks gestation │
│ ➤ Consider admission (risk of pneumonitis) │
│ ➤ If <20 weeks: risk of congenital varicella syndrome │
│ ➤ If near term: risk of severe neonatal varicella │
│ │
│ NEONATE: │
│ ➤ IV aciclovir immediately │
│ ➤ High mortality if untreated │
│ │
│ POST-EXPOSURE PROPHYLAXIS (within 10 days of exposure): │
│ ➤ VZIG for high-risk contacts (pregnant, neonate, immuno) │
│ ➤ Vaccine (if eligible) within 5 days of exposure │
└───────────────────────────────────────────────────────────────┘
Post-Exposure Prophylaxis
| Agent | Indication | Timing |
|---|---|---|
| VZIG | Immunocompromised; pregnant (non-immune); neonates | Within 10 days of exposure |
| Varicella vaccine | Healthy non-immune contacts | Within 3-5 days of exposure |
Why Avoid NSAIDs?
- Association with invasive Group A Streptococcal infection
- Increased risk of necrotising fasciitis in chickenpox
- NICE and PHE advise paracetamol only for fever
Early Complications
| Complication | Incidence | Management |
|---|---|---|
| Secondary bacterial skin infection | 5-10% | Antibiotics (flucloxacillin); watch for GAS |
| Necrotising fasciitis | Rare but severe | Urgent surgical debridement + IV antibiotics |
| Varicella pneumonitis | 1:400 adults | IV aciclovir; respiratory support |
| Encephalitis | 1:4,000 | Supportive; consider IV aciclovir |
| Cerebellar ataxia | 1:4,000 | Self-limiting (usually); supportive |
| Thrombocytopenia | Rare | Usually self-limiting |
Late Complications
| Complication | Notes |
|---|---|
| Herpes zoster (shingles) | VZV reactivation; typically years later |
| Post-herpetic neuralgia | Complication of shingles (not primary chickenpox) |
| Scarring | From scratching/secondary infection |
Pregnancy-Specific Complications
| Timing of Maternal Infection | Risk |
|---|---|
| Weeks 1-12 | 0.5% risk of congenital varicella syndrome (limb hypoplasia, cicatricial skin lesions, eye abnormalities, neurological damage) |
| Weeks 13-20 | 2% risk of congenital varicella syndrome |
| Weeks 20+ | Shingles in infancy; no congenital syndrome |
| 5 days before to 2 days after delivery | Severe neonatal varicella (up to 30% mortality without treatment) |
Outcomes in Healthy Children
| Outcome | Expected |
|---|---|
| Duration of illness | 5-10 days |
| Full recovery | >99% |
| Mortality | ~1 per 100,000 cases |
| Scarring | Common if scratching/secondary infection |
Outcomes in High-Risk Groups
| Group | Risk |
|---|---|
| Adults | 25x higher mortality than children |
| Immunocompromised (untreated) | 10-30% mortality |
| Pregnant (pneumonitis) | Up to 10% mortality without treatment |
| Neonatal varicella (untreated) | 20-30% mortality |
Key Guidelines
| Guideline | Organisation | Year | Key Points |
|---|---|---|---|
| Chickenpox CKS | NICE | Updated 2023 | Diagnosis, management, referral criteria |
| Post-exposure prophylaxis | PHE/UKHSA | 2019 | VZIG indications, timing |
| Varicella vaccination | JCVI/Green Book | 2022 | Vaccine schedules, targeted use |
Landmark Studies
Varicella Vaccine Efficacy (Kuter et al. 1991)
- Demonstrated 95% efficacy in preventing varicella
- Foundation for routine childhood vaccination
- PMID: 1651974
NSAIDs and Necrotising Fasciitis (Lesko et al. 2001)
- Case-control study showing association between NSAIDs and NF in chickenpox
- Basis for avoiding ibuprofen
- PMID: 11178117
Evidence Strength
| Intervention | Level | Evidence |
|---|---|---|
| Varicella vaccination | 1a | RCTs, real-world effectiveness data |
| Aciclovir in high-risk groups | 1b | RCTs |
| Avoidance of NSAIDs | 2a | Observational studies |
| VZIG for post-exposure prophylaxis | 2a | Cohort studies |
What is Chickenpox?
Chickenpox is a common and very contagious infection caused by the varicella-zoster virus. It causes an itchy rash of blisters that appear all over the body. Most children get it before age 10.
What are the symptoms?
- Fever and feeling unwell for 1-2 days
- Rash that starts as small red spots, then becomes blisters filled with fluid
- Blisters appear in waves — you'll see spots at different stages at the same time
- Very itchy
- Blisters eventually dry up and form scabs
How is it spread?
Chickenpox is very contagious. It spreads through:
- Coughs and sneezes (airborne droplets)
- Direct contact with blister fluid
A child is infectious from 2 days before the rash appears until all blisters have crusted over (usually 5-7 days).
How to treat it at home
- Give paracetamol (NOT ibuprofen) for fever and discomfort
- Use calamine lotion or cooling gels to soothe itching
- Give antihistamines (like Piriton) to help with itching
- Keep fingernails short and consider mittens at night
- Dress in loose, cool clothing
- Oatmeal baths can be soothing
- Keep your child hydrated
When to call a doctor
Seek medical advice if:
- High fever lasting more than 4 days
- Rash becomes very red, warm, or painful (infection)
- Difficulty breathing or persistent cough
- Unusual drowsiness, confusion, or headache
- Your child won't drink or is dehydrated
- Your child is very young (<1 year), immunocompromised, or unwell
Guidelines
-
NICE Clinical Knowledge Summaries. Chickenpox. 2023. cks.nice.org.uk
-
UKHSA. Guidance on varicella-zoster post-exposure prophylaxis. 2019. gov.uk
Key Studies
-
Kuter BJ, Weibel RE, Guess HA, et al. Oka/Merck varicella vaccine in healthy children. Pediatr Infect Dis J. 1991;10(10):719-722. PMID: 1651974
-
Lesko SM, O'Brien KL, Schwartz B, et al. Invasive group A streptococcal infection and nonsteroidal anti-inflammatory drug use among children with primary varicella. Pediatrics. 2001;107(5):1108-1115. PMID: 11331692
Reviews
-
Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1365-1376. PMID: 17046470
-
NHS. Chickenpox information. nhs.uk/conditions/chickenpox
High-Yield Exam Topics
| Topic | Key Points |
|---|---|
| Rash description | "Dew drops on a rose petal"; crops at different stages; centripetal distribution |
| Infectious period | 2 days before rash until all lesions crusted (~5-7 days) |
| Avoid NSAIDs | Association with necrotising fasciitis |
| Aciclovir indications | Adults, immunocompromised, pregnant, within 24h of rash onset |
| VZIG | For high-risk contacts (immunocompromised, pregnant, neonate) within 10 days |
| Latency | VZV dormant in dorsal root ganglia → reactivates as shingles |
Sample Viva Questions
Q1: A 5-year-old presents with an itchy vesicular rash. How do you manage this?
Model Answer: This is likely chickenpox in a healthy child. Diagnosis is clinical based on the typical rash (crops of vesicles at different stages, centripetal distribution). Management is supportive: paracetamol for fever (NOT NSAIDs due to necrotising fasciitis risk), antihistamines and calamine for itch, keep nails short. Advise parents the child is infectious until all lesions are crusted over (~5-7 days). No antivirals needed for a healthy child. I would ask about contacts who might be high-risk (pregnant women, immunocompromised, neonates) and advise accordingly.
Q2: Why should NSAIDs be avoided in chickenpox?
Model Answer: NSAIDs (particularly ibuprofen) have been associated with an increased risk of invasive Group A Streptococcal infection and necrotising fasciitis in children with chickenpox. Observational studies, including Lesko et al., demonstrated this association. The mechanism may involve masking early signs of infection, impairing neutrophil function, or direct effects on bacterial virulence. NICE and PHE guidelines recommend paracetamol only for symptomatic relief in chickenpox.
Q3: A pregnant woman at 10 weeks gestation is exposed to chickenpox. What is your management?
Model Answer: First, I would check her immunity status. If she has a history of chickenpox or is IgG positive, she is immune and no action is needed. If she is non-immune (IgG negative) and has been significantly exposed (same room for >15 minutes, face-to-face contact, same household), she is at risk of varicella and its complications (pneumonitis, and congenital varicella syndrome). I would administer VZIG as soon as possible (ideally within 10 days of exposure) to prevent or attenuate infection. If she develops varicella, treatment is with aciclovir (especially if ≥20 weeks), and she should be monitored closely for pneumonitis. Detailed fetal medicine follow-up is required for risk of congenital varicella syndrome, which is ~2% when infection occurs between weeks 13-20.
Common Exam Errors
| Error | Correct Approach |
|---|---|
| Prescribing ibuprofen | Use paracetamol only — NSAIDs increase NF risk |
| Giving antivirals to all children | Antivirals only for high-risk groups (adults, immunocompromised, pregnant) |
| Saying chickenpox is infectious only when rash visible | Infectious 2 days BEFORE rash appears |
| Forgetting VZIG for high-risk contacts | VZIG within 10 days for pregnant, immunocompromised, neonate contacts |
| Confusing congenital varicella syndrome timing | Risk is <20 weeks gestation; after 20 weeks = shingles in infancy, not CVS |
Last Reviewed: 2025-12-24 | MedVellum Editorial Team
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists.